Results 161 to 170 of about 18,251 (231)

Alendronate Alters the Release of EVs by Raw 264.7 Osteoclasts. [PDF]

J Histochem Cytochem
Faria LP, Arana-Chavez VE, Holliday LS.
europepmc   +1 more source

Fragility fracture, atypical femoral fracture, and osteonecrosis of jaw after bisphosphonate prescription for three and five years, based on primary and secondary care data in England: nested case-control and cohort studies. [PDF]

BMJ Med
Nakafero G, McKeever T, Kukreja NS, Welsh V, Muller S, Abhishek A.   +5 more
europepmc   +1 more source

Real-World Comparability of Antiresorptive Osteoporosis Treatment Groups Among Treatment-Naïve and Treatment-Experienced Women Ages 55 and Older in the United States. [PDF]

Clin Epidemiol
Hurwitz KE, Feinstein L, Pritchard DA, Samai P, Yu Y, Kim M, Balasubramanian A, Lin TC, Bradbury BD, Brookhart MA.   +9 more
europepmc   +1 more source

Health and adverse events associated with extended oral bisphosphonates among postmenopausal women: a systematic review.

J Clin Endocrinol Metab
Oka P, Moosa AS, Koh EYL, Ng CJ.
europepmc   +1 more source

Bisphosphonates and Periodontal Health: A Systematic Review in Postmenopausal Women. [PDF]

J Midlife Health
Gangolu M, Jaswitha V, Boyapati R, Dhulipalla R, Maddukuri T, Pasupuleti SC.   +5 more
europepmc   +1 more source

Microfluidic Fabrication of Alendronate-Modified Lipid Nanoparticles for Bone-Targeted mRNA Delivery. [PDF]

Pharmaceutics
Xu K, Su J, Ma H, Zhu Y.
europepmc   +1 more source

Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.

J Clin Endocrinol Metab
Ferrari S, Betah D, Feldman RG, Langdahl BL, Oates M, Timoshanko J, Wang Z, Dhaliwal R.   +7 more
europepmc   +1 more source